FluMist is the only nasal flu vaccine ... could lead to increased flu vaccination rates. The maker of the vaccine, AstraZeneca, said it will supply the vaccine to a third-party online pharmacy ...

The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to ... The FluMist vaccine, manufactured by AstraZeneca, had previously been approved ...

The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for self-administration. The approval makes FluMist the only 'flu vaccine ...

The F.D.A. authorized AstraZeneca’s treatment to be given ... opening the door for needle-shy people to have easy access to a nasal spray vaccine that is potentially lifesaving.

Sept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's (AZN.L), opens new tab nasal spray flu vaccine for self-administration, making it the first ...

In AstraZeneca’s trial, 100% of adults were able to administer a full dose to themselves. The ease of giving the nasal spray vaccine is good news for both kids and needle-nervous people ...

The nasal spray flu vaccine platform for at-home use will be available sometime next Fall, an AstraZeneca spokesperson told ABC News. The FDA Friday approved the flu vaccine that can be done at ...

AstraZeneca established its vaccines unit after collaborating with the University of Oxford to develop a COVID-19 vaccine. The existing site, currently used for producing the nasal flu vaccine ...

But he said he hoped it would lead to increased awareness, potentially through more marketing from AstraZeneca or more research into additional intranasal vaccines that are easier to get.